World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
107
Citations
40978
World Ranking
614
National Ranking
75

Medicine

D-Index
107
Citations
40978
World Ranking
6275
National Ranking
610

Overview

Thomas Foltynie is affiliated with University College London in the United Kingdom. Their research primarily focuses on the fields of Medicine and Neuroscience, with significant contributions to subfields such as Neurology, Cellular and Molecular Neuroscience, Cognitive Neuroscience, Molecular Biology, and Physiology.

The main topics addressed in Foltynie's work include:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Genetic Neurodegenerative Diseases
  • Transcranial Magnetic Stimulation Studies
  • Autism Spectrum Disorder Research
  • Neuroscience and Neural Engineering

Their recent papers demonstrate a focus on Parkinson's disease and related neurological conditions. Notable publications include:

  • "Progress towards therapies for disease modification in Parkinson's disease," 2021, The Lancet Neurology
  • "Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations," 2020, JAMA Neurology
  • "The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease," 2020, Journal of Parkinson's Disease
  • "Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes," 2020, Brain
  • "Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome," 2021, Nature Communications

Foltynie has collaborated extensively with other researchers, working most frequently with:

  • Patricia Limousin
  • Ludvic Zrinzo
  • Harith Akram
  • Nirosen Vijiaratnam
  • Huw R. Morris

Their work has appeared in several publication venues with multiple contributions, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Movement Disorders
  • Movement Disorders Clinical Practice
  • Journal of Parkinson's Disease
  • Brain

Best Publications

  • Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    Mike A Nalls;Cornelis Blauwendraat;Costanza L Vallerga;Karl Heilbron

  • Adaptive deep brain stimulation in advanced Parkinson disease

    Simon Little;Alex Pogosyan;Spencer Neal;Baltazar Zavala

  • Evolution of cognitive dysfunction in an incident Parkinson's disease cohort

    C. H. Williams-Gray;T. Foltynie;C. E. G. Brayne;T. W. Robbins

  • The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

    Caroline H. Williams-Gray;Jonathan R. Evans;An Goris;An Goris;Thomas Foltynie

  • Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

    D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub

  • The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

    Thomas Foltynie;Carol E. G. Brayne;Trevor W. Robbins;Roger A. Barker

  • Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    Dilan Athauda;Kate Maclagan;Simon S Skene;Martha Bajwa-Joseph

  • The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

    Caroline H Williams-Gray;Sarah L Mason;Jonathan R Evans;Thomas Foltynie

  • Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach

    S J G Lewis;T Foltynie;A D Blackwell;T W Robbins

  • Exenatide and the treatment of patients with Parkinson’s disease

    Iciar Aviles-Olmos;John Dickson;Zinovia Kefalopoulou;Atbin Djamshidian

  • Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease

    Vladimir Litvak;Vladimir Litvak;Ashwani Jha;Ashwani Jha;Alexandre Eusebio;Robert Oostenveld

  • Parkinson's disease dementia: a neural networks perspective

    James Gratwicke;Marjan Jahanshahi;Thomas Foltynie

  • Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients

    A Eusebio;W Thevathasan;L Doyle Gaynor;A Pogosyan

  • Long-term outcomes of deep brain stimulation in Parkinson disease

    Patricia Limousin;Tom Foltynie

  • The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action.

    Dilan Athauda;Thomas Foltynie

  • Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

    A. Beilina;I. N. Rudenko;A. Kaganovich;L. Civiero

  • Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review.

    Ludvic Zrinzo;Thomas Foltynie;Patricia Limousin;Marwan I. Hariz;Marwan I. Hariz

  • Bilateral adaptive deep brain stimulation is effective in Parkinson's disease

    Simon Little;Martijn Beudel;Ludvic Zrinzo;Thomas Foltynie

  • A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease

    V. Plagnol;M.A. Nalls;J.M. Bras;D.G. Hernandez;D.G. Hernandez

  • Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging.

    Christian Lambert;Ludvic U. Zrinzo;Zoltán Nagy;Antoine Lutti

Frequent Co-Authors

Patricia Limousin
Patricia Limousin University College London
Ludvic Zrinzo
Ludvic Zrinzo University College London
Marwan Hariz
Marwan Hariz Umeå University
Peter Brown
Peter Brown University of Oxford
Roger A. Barker
Roger A. Barker University of Cambridge
Marjan Jahanshahi
Marjan Jahanshahi University College London
Nicholas W. Wood
Nicholas W. Wood University College London
Andrew J. Lees
Andrew J. Lees University College London
Huiling Tan
Huiling Tan University of Oxford
Kailash P. Bhatia
Kailash P. Bhatia University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying neuroscience paves the way for a wide range of career opportunities, and many students seek flexible options to enhance their credentials. Certifications that pay well can open doors to specialized roles and boost earning potential, even outside traditional neuroscience careers.

If you’re considering gaining foundational knowledge before diving into advanced topics, exploring online college courses in related subjects can be a smart and accessible starting point.

For those interested in the behavioral or clinical sides of neuroscience, social work and applied behavior analysis are popular complementary pathways. Accredited distance programs, such as the cheapest online MSW programs and accessible BCBA certification programs, offer affordable ways to upskill and qualify for in-demand roles.

Whether you’re looking to advance your neuroscience education or branch into adjacent fields, these online pathways support new career possibilities with flexibility and cost efficiency.

Best Scientists Citing Thomas Foltynie

Trending Scientists